CTNM
Contineum Therapeutics, Inc.
13.20$
-4.0%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | -100.0% | – | |
| – | – | -40.7% | +32.3% | +25.2% | |
| – | – | – | -100.5% | – | |
| – | -24.4% | +63.4% | +38.3% | +35.0% | |
| – | -7.3% | +8.5% | +97.3% | +32.6% | |
| – | -20.7% | +190.8% | -23.4% | +34.4% | |
| – | – | – | – | – | |
| – | +16.9% | -46.4% | -100.0% | – | |
| – | – | – | -282.4% | – | |
| – | – | – | – | – | |
| – | – | – | -286.0% | – | |
| – | – | – | -278.2% | – |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.